Rift Valley Fever Virus Propagates in Human Villous Trophoblast Cell Lines and Induces Cytokine mRNA Responses Known to Provoke Miscarriage
Open Access
Abstract
The mosquito-borne Rift Valley fever (RVF) is a prioritised disease that has been listed by the World Health Organization for urgent research and development of counteraction. Rift Valley fever virus (RVFV) can cause a cytopathogenic effect in the infected cell and induce hyperimmune responses that contribute to pathogenesis. In livestock, the consequences of RVFV infection vary from mild symptoms to abortion. In humans, 1–3% of patients with RVFV infection develop severe disease, manifested as, for example, haemorrhagic fever, encephalitis or blindness. RVFV infection has also been associated with miscarriage in humans. During pregnancy, there should be a balance between pro-inflammatory and anti-inflammatory mediators to create a protective environment for the placenta and foetus. Many viruses are capable of penetrating that protective environment and infecting the foetal–maternal unit, possibly via the trophoblasts in the placenta, with potentially severe consequences. Whether it is the viral infection per se, the immune response, or both that contribute to the pathogenesis of miscarriage remains unknown. To investigate how RVFV could contribute to pathogenesis during pregnancy, we infected two human trophoblast cell lines, A3 and Jar, representing normal and transformed human villous trophoblasts, respectively. They were infected with two RVFV variants (wild-type RVFV and RVFV with a deleted NSs protein), and the infection kinetics and 15 different cytokines were analysed. The trophoblast cell lines were infected by both RVFV variants and infection caused upregulation of messenger RNA (mRNA) expression for interferon (IFN) types I–III and inflammatory cytokines, combined with cell line-specific mRNA expression of transforming growth factor (TGF)-β1 and interleukin (IL)-10. When comparing the two RVFV variants, we found that infection with RVFV lacking NSs function caused a hyper-IFN response and inflammatory response, while the wild-type RVFV suppressed the IFN I and inflammatory response. The induction of certain cytokines by RVFV infection could potentially lead to teratogenic effects that disrupt foetal and placental developmental pathways, leading to birth defects and other pregnancy complications, such as miscarriage.Keywords
Funding Information
- Vetenskapsrådet (2018-02637)
- Medical Faculty, Umeå University (2018)
- Region Västerbotten, basic ALF-grant (2018, 2019, 2020)
This publication has 58 references indexed in Scilit:
- Intrauterine infection and preterm laborSeminars in Fetal and Neonatal Medicine, 2012
- Cell linesSpermatogenesis, 2012
- Postepidemic Analysis of Rift Valley Fever Virus Transmission in Northeastern Kenya: A Village Cohort StudyPLOS Neglected Tropical Diseases, 2011
- NSs Protein of Rift Valley Fever Virus Promotes Posttranslational Downregulation of the TFIIH Subunit p62Journal of Virology, 2011
- Placental TNF-α Signaling in Illness-Induced Complications of PregnancyThe American Journal of Pathology, 2011
- Alteration in Superoxide Dismutase 1 Causes Oxidative Stress and p38 MAPK Activation Following RVFV InfectionPLOS ONE, 2011
- The Pathogenesis of Rift Valley FeverViruses, 2011
- Prediction of Spontaneous Preterm Delivery in Women With Preterm LaborObstetrics & Gynecology, 2009
- T7 RNA polymerase-dependent and -independent systems for cDNA-based rescue of Rift Valley fever virusJournal of General Virology, 2008
- Maternal Immune Activation Alters Fetal Brain Development through Interleukin-6The Journal of Neuroscience, 2007